InvestorsHub Logo
Followers 8
Posts 2073
Boards Moderated 0
Alias Born 04/23/2018

Re: None

Tuesday, 12/08/2020 12:59:48 PM

Tuesday, December 08, 2020 12:59:48 PM

Post# of 81
Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria

https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-receives-fda-rare-pediatric-disease-designation-for-acn00177-for-the-treatment-of-homocystinuria-301182095.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AGLE News